21 Recruiting Trials

Clinical Trials for COPD in New York

21 clinical trials for COPD are currently recruiting participants at study sites in New York. Study-related care is provided at no cost.

Showing 15 of 21 recruiting COPD trials in New York

A Study to Evaluate Solrikitug in Participants With COPD (ZION)
PHASE2 Birmingham, Alabama +4 sites NCT06496620
Recruiting
Recruiting
SPIROMICS Study of Early COPD Progression (SOURCE)
N/A Birmingham, Alabama +4 sites NCT05033990
Recruiting
PiMZ Longitudinal Cohort (PiMZ Logic)
N/A New York, New York +4 sites NCT06505603
Recruiting

COPD clinical trials in New York: common questions

How many COPD clinical trials are recruiting in New York?
TrialFinder currently lists 21 recruiting COPD clinical trials with study sites in New York. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are COPD clinical trials located in New York?
Study sites for the COPD trials listed on this page include New York. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a COPD clinical trial in New York?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many COPD trials in New York also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a COPD clinical trial in New York?
Each study sets its own criteria based on age, COPD diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.

Check Your Eligibility

Create a free profile and our AI will match you to COPD trials near you in New York.

Get Matched — Free
No insurance required

COPD trials investigate bronchodilators, anti-inflammatory biologics, pulmonary rehabilitation, and lung-volume reduction procedures for chronic obstructive lung disease.

All COPD trials →